VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 74 filers reported holding VERVE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $305 | -28.7% | 23,033 | +0.9% | 0.00% | -100.0% |
| Q2 2023 | $428 | +18.9% | 22,834 | -8.7% | 0.00% | – |
| Q1 2023 | $360 | -39.4% | 24,998 | -18.5% | 0.00% | -100.0% |
| Q4 2022 | $594 | -99.9% | 30,685 | +0.1% | 0.00% | -50.0% |
| Q3 2022 | $1,053,000 | +155.6% | 30,642 | +13.7% | 0.00% | +100.0% |
| Q2 2022 | $412,000 | -32.8% | 26,961 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $613,000 | -43.7% | 26,847 | -9.0% | 0.00% | 0.0% |
| Q4 2021 | $1,088,000 | +41.5% | 29,507 | +80.4% | 0.00% | 0.0% |
| Q3 2021 | $769,000 | – | 16,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $661,184,000 | 13.47% |
| Casdin Capital, LLC | 3,038,167 | $183,050,000 | 4.65% |
| Logos Global Management LP | 758,265 | $45,685,000 | 3.84% |
| Novo Holdings A/S | 793,265 | $47,794,000 | 2.12% |
| Redmile Group, LLC | 1,936,530 | $116,676,000 | 1.73% |
| Cormorant Asset Management, LP | 709,224 | $40,594,000 | 1.38% |
| Rock Springs Capital Management LP | 962,826 | $58,011,000 | 1.15% |
| Asymmetry Capital Management, L.P. | 24,790 | $1,494,000 | 1.03% |
| Darwin Global Management, Ltd. | 103,013 | $6,207,000 | 1.00% |
| RA Capital Management | 880,284 | $53,037,000 | 0.85% |